Brain-derived neurotrophic factor (BDNF) is a candidate molecule for regulating activity-dependent synaptic plasticity on the grounds of its expression pattern in developing visual cortex and that of its receptor, trkB (Castré n et al., 1992; Bozzi et al., 1995; Schoups et al., 1995; Cabelli et al., 1996) , as well as the modulation of these patterns by activity (Castré n et al., 1992; Bozzi et al., 1995; Schoups et al., 1995) . Infusing trkB ligands or their neutralizing agents, the trkB-IgG fusion proteins, into visual cortex alters the development and plasticity of ocular dominance columns (Cabelli et al., 1995; Riddle et al., 1995; Galuske et al., 1996; Gillespie et al., 1996; Cabelli et al., 1997) . To test further the physiological role of BDNF, we studied a transgenic mouse that expresses elevated levels of BDNF in primary visual cortex (V1) postnatally (Huang et al., 1999) . We found that unlike the infusion experiments, excess BDNF expressed in mouse visual cortex did not block ocular dominance plasticity. Instead, single neurons in V1 of the BDNF transgenic mice were as susceptible to the effects of monocular deprivation (MD) as neurons in wild-type mice, but only during a precocious critical period. At a time when V1 in the wild-type mouse responded maximally to a 4 d MD with a reduction in its response to deprived eye visual stimulation, the transgenic mouse V1 had already passed the peak of its precocious critical period and no longer responded maximally. This finding suggests a role for BDNF in promoting the postnatal maturation of cortical circuitry.
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Several experiments implicate brain-derived neurotrophic factor (BDN F) in models of neuronal plasticity in vitro, including the enhancement of cortical cell dendritic morphology (McAllister et al., 1995) , the enhancement of synaptic transmission (Kang and Schuman, 1995; C armignoto et al., 1997; Rutherford et al., 1998) , and the induction and maintenance of long-term potentiation in hippocampus (Korte et al., 1995; Figurov et al., 1996; Patterson et al., 1996) . Results from experiments in vivo are also consistent with the idea that competition for limiting quantities of BDNF or other endogenous trkB ligands regulates synaptic plasticity during development of visual cortex by acting as the "reward" for the more active inputs that are more successf ul in driving the postsynaptic partners. In carnivores, providing excess trkB ligand blocks the f urther segregation of geniculocortical inputs into nascent ocular dominance columns and, perhaps by rewarding deprived and nondeprived inputs indiscriminately, prevents the usual loss of responsiveness of cortical neurons to the deprived eye after monocular deprivation (MD) (C abelli et al., 1995 Galuske et al., 1996; Gillespie et al., 1996) . Blocking endogenous trkB ligands also alters cortical development (C abelli et al., 1997) . In addition to its effects on excitatory neurons, BDNF is also known to affect inhibitory circuitry in cortical neurons (Rutherford et al., 1997) .
The role of neurotrophins in the development and plasticity of rodent visual cortex is well established. Exogenous nerve growth factor (NGF) in rats can block ocular dominance plasticity or substitute for visual experience, and antibodies to NGF block normal development of cortical visual responses despite normal visual experience (Maffei et al., 1992; Berardi et al., 1994; Fagiolini and Stryker, 1996; Fagiolini et al., 1997) . In most earlier experiments, exogenous BDNF has been applied pharmacologically in high concentration. In transgenic mice in which a BDNF transgene was linked to the calcium/calmodulin-dependent kinase II ␣ (␣CaMKII) promoter, the levels of BDNF in cortex were only moderately elevated in the cells that normally express BDNF (Huang et al., 1999) . Abnormalities in such animals could illuminate the physiological roles played by BDNF in visual cortical development.
As in wild-type animals, neocortical levels of BDNF in BDNF-overexpressing transgenic mice increased during postnatal development. BDN F mRNA expression in the cerebral cortex of the transgenic mice was accelerated by postnatal day 2 (P2), at which time the wild-type littermates showed very low levels of endogenous BDN F. By 3 weeks of age, total BDN F mRNA levels in the transgenic neocortex were significantly higher than those in wildtype animals of 5 weeks of age. At 5 weeks, BDN F mRNA levels in transgenic mouse neocortex were three times normal, and in adult transgenic mice, they were five times normal (Huang et al., 1999) .
MATERIALS AND METHODS
Generation of mutant mice. Mice were generated as described previously (Huang et al., 1999) . In the present study, experiments were performed on the A9 line of mice. In these animals, the expression pattern of the transgene was mainly restricted to forebrain, including the neocortex and hippocampus. Within the cortex, the expression of the transgene had the laminar pattern of the endogenous genes for BDN F or ␣C aM K II. In the visual cortex of both transgenic and wild-type animals, highest levels of BDN F expression were in layers II / III and V/ V I; however, in transgenic animals, BDN F expression levels were substantially higher in all cortical layers. These higher levels of BDN F expression resulted from increase in the number of neurons expressing BDN F as well as an increase in the intensity of BDN F immunoreactivity in the neurons. In addition, the transgene appeared not to be expressed by neurons with inhibitory markers (Huang et al., 1999) . Monocular deprivation. Lid sutures were performed as described (Gordon and Stryker, 1996) , except that anesthesia was produced using 2.5% isoflurane (Abbott, North Chicago, IL) in oxygen. Animals were checked daily to make sure that the sutured eye remained closed. If any sutures appeared loose, they were replaced under anesthesia. In the cases in which holes were apparent and the eye could have been exposed, the animals were removed from the study.
Electrophysiolog y. Mice were prepared blind to genotype under Nembutal (50 mg / kg; Abbott) and chlorprothixene (0.2 mg; Sigma, St. L ouis, MO) anesthesia using standard protocol (Gordon and Stryker, 1996) . In each animal, single cells separated by at least 50 m were recorded from multiple penetration sites within the V1 binocular zone (BZ) contralateral to the deprived eye using extracellular tungsten microelectrodes. All recordings were contralateral to the deprived eye. Receptive fields were plotted on a tangent screen with a hand-held projection lamp or computer-generated stimuli. Only cells with receptive fields within the central 25°of the visual hemifield were included in this study. The cells were assigned to an ocular dominance group according to the classification scheme of Hubel and Wiesel (1962) . C ells were assigned to group 1 if they responded only to stimuli presented to the contralateral (deprived) eye and 7 if they responded only to stimuli presented to the ipsilateral (nondeprived) eye. C ells responding equally well to stimuli presented to each eye individually were assigned to group 4, and groups 2 or 3 and 5 or 6 indicated cells responding better to stimuli presented to the contralateral and ipsilateral eyes, respectively. Ocular dominance histograms such as in Figure 2a -h show percent of cells as a f unction of ocular dominance group. The contralateral bias index (CBI ) was then calculated, a weighted average of the bias for one eye or the other, with the following formula:
where n ϭ total number of cells, and n x ϭnumber of cells with ocular dominance scores equal to x. Each neuron was also assigned a habituation score on a scale of 0 to 3; a score of 0 indicated a neuron that responded vigorously to each stimulation in a series, whereas a score of 3 indicated a neuron that habituated maximally after each presentation of the stimulus.
RESULTS

Visual responsiveness
To interpret the following experiments on cortical plasticity, it was important to ensure that the neurons in the transgenic mouse V1 were visually responsive. In transgenic (Tg) and wild-type (WT) mice at all ages studied, neurons responded to oriented bars of light moving across their respective receptive fields (Fig.  1a,b) . Retinotopic organization was preserved in transgenic mice and was similar to that in wild-type mice (Fig. 1c,d ). Both transgenic and wild-type adult, nondeprived mice showed a contralateral bias in the V1 BZ as well (Tg mean CBI ϭ 0.8, four mice; WT mean CBI ϭ 0.68, four mice); the transgenic mean CBI was significantly higher than the wild-type mean CBI ( p Ͻ 0.05, Mann -Whitney U test). In addition, the degree of habituation of neuronal responses to repeated stimulus presentations (see Materials and Methods) was similar in transgenic and wild-type adult mice (mean habituation scores, Tg ϭ 1.28; W T ϭ 1.16) and deprived juvenile mice (Tg ϭ 1.3; W T ϭ 1.1). Therefore, defects in plasticity are not likely to be artifactually attributable to defects in visual responsiveness or overall cortical organization.
Ocular dominance plasticity assessed from pooled data
We studied developmental plasticity in the BZ of the transgenic mouse V1 by measuring the changes produced by MD in the relative responses of single neurons to input through each eye. In wild-type C57BL6 mice, a 4 d MD at the peak of the critical period for ocular dominance plasticity (P26 -P32) produces the maximal shift in ocular dominance in the BZ (Gordon and Stryker, 1996) , such that cells are now more responsive to input through the nondeprived eye. This plasticity occurs via activitydependent competition between inputs from the two eyes in V1 BZ (Gordon and Stryker, 1996) . We performed 4 d MDs in 24 transgenic and 28 wild-type mice beginning between P19 and P34, ages before and during the normal critical period. Still blind to genotype, we assessed the ocular dominance distribution in the BZ contralateral to the deprived eye with extracellular single-unit recordings in vivo. Each isolated unit was assigned to an ocular dominance group between 1 and 7 (see Materials and Methods). The grouping of the cells was then used to calculate the CBI, which describes the ocular dominance distribution of the neurons in a particular cortical hemisphere (see Materials and Methods). In normal mice, the CBI is ϳ0.7, indicating a substantial bias in favor of the contralateral eye (Gordon and Stryker, 1996) . A lower CBI (closer to 0) indicates a greater relative response to the ipsilateral eye. In our case, the contralateral eye was deprived, so a low CBI indicated an ocular dominance shift in response to MD.
The overexpression of BDNF in the transgenic mouse V1 did not prevent ocular dominance plasticity. Indeed, plasticity in the BDNF transgenic mice was at least as great as normal, but it was precocious. At the earliest deprivations (P19 -P20) studied, the ocular dominance distributions were similar for the two genotypes (Fig. 2a,b) , and most neurons responded better to the contralateral eye despite its deprivation. After MD with start dates of P21-P23, the ocular dominance of neurons in the transgenic mouse BZ was shifted substantially (Fig. 2c) , whereas the wild-type mice did not yet respond to MD to the same extent and maintained a cortex preferentially responsive to the contralateral (deprived) eye (Fig. 2d) . The critical period for the transgenic mice had ended before P27, because when MD was performed starting at or after that date, neurons in V1 remained responsive to the deprived eye, and the ocular dominance distribution was entirely like that of a normal nondeprived animal ( Fig. 2g ; compare with Gordon and Stryker, 1996, their Fig. 2 ). In contrast, the ocular dominance distribution of wild-type animals deprived after P27 was shifted substantially away from the deprived eye deprived at the different ages are overlaid with smooth curves (solid line, Tg; dotted line, W T) generated by three-point boxcar averaging to compare the time courses of plasticity for the two genotypes. The peak (lowest CBI value) for the Tg mouse V1 plasticity comes at ϳP22-P23, during which time the W T mouse V1 is nearly unresponsive to MD. The peak for the W T mouse V1 plasticity comes later, at ϳP25, when the Tg mice have begun to respond less to MD.
( Fig. 2h) , consistent with the peak of the normal critical period for plasticity in mouse V1 (Gordon and Stryker, 1996) . Deprivations beginning at the transitional times between P24 and P26 showed an intermediate result. The transgenic neurons still shifted but less so than earlier (Fig. 2, compare e, c) , and the shift in the wild-type neurons had just begun (Fig. 2, compare f, d ).
Analysis in individual mice
The analysis above was based on pooling the neurons recorded in different animals. The precocious end to the critical period in the transgenic mice was also evident in the mean CBI values for the different age groups, with the data from each animal equally weighted. Figure 2i shows that before the normal critical period, the mean CBI for the transgenic mice was shifted maximally and was significantly lower ( p Ͻ 0.01, Mann -Whitney U test) than that of the wild-type mice when MD started between P21 and P23. Later, when wild-type mice were still within the peak of their critical period (MD beginning between P27 and P34), the mean CBI for the transgenic mice with MD was significantly higher ( p Ͻ 0.01, Mann -Whitney U test) than that of the wild-type mice (Fig. 2 i) . The mean CBI for the transgenic mice was also significantly higher ( p Ͻ 0.01, Mann -Whitney U test) than it had been with earlier deprivations, indicating that with MD beginning between P27 and P34, the transgenic mice did not exhibit a maximal shift. Figure 3 shows the CBI for each individual deprived mouse, along with smooth curves tracing the course of visual cortical plasticity in the two genotypes. V1 in transgenic mice responded maximally to MD at ϳP22, earlier than in wild-type mice. Then the transgenic mice passed this premature peak of their critical period, and the curves for the two genotypes crossed, as V1 in wild-type mice approached its time of maximal ocular dominance shift. After P27, V1 in the transgenic mice no longer shifted, whereas in wild-type mice it continued to do so.
Analysis of matched pairs
In creating these transgenic mice, the founders were back-crossed into the C57BL6 line, introducing a possible artifact from variation in background strain expression between different litters. This was controlled for by comparing pairs of transgenic and wild-type mice within single litters, deprived within 1 d of each other. Figure 4 shows the results of these comparisons with littermate controls. Again, with MDs starting P21-P23, the transgenic mouse of each pair had a significantly lower CBI than its wild-type littermate ( p Ͻ 0.05, paired t test), consistent with the premature plasticity of the transgenic mouse V1. Later, with MDs starting P27-P34, the transgenic mice had significantly higher CBI values than the wild-type littermates ( p Ͻ 0.05, paired t test), indicating a premature close to the transgenic mouse critical period.
DISCUSSION
How can one reconcile the present results, in which overexpressed BDNF precociously enhances and prematurely ends activitydependent plasticity, with the evidence from pharmacological application of BDNF and other trkB ligands, in which activitydependent plasticity is blocked (Cabelli et al., 1995; Riddle et al., 1995; Gillespie et al., 1996) ? The pharmacological experiments have been interpreted as evidence that trkB ligand is the signal by which activity promotes the growth and maintenance of connections, which are made inappropriately if the requirement for activity is short-circuited by excess trkB ligand. One possibility is that the release of the overexpressed BDNF in our transgenic mice is regulated normally, so that despite its higher level of expression, it does not short-circuit activity-dependent processes and may even enhance them. A second possibility is that BDNF is not the mediator of activity-dependent plasticity but merely promotes growth of connections until they are mature, after which it loses its effect. Both the lack of effect of exogenous trkB ligand in visual cortex after the end of the critical period (Gillespie, 1998) and the premature end of the critical period in our transgenic mice are consistent with this second possibility. The present results provide unequivocal evidence for the effect of BDNF on early maturation, and they are also consistent with the first possibility that endogenous trkB ligands may mediate activity-dependent plasticity in visual cortex.
BDNF may produce its effect on maturation by modulating inhibitory circuitry in the visual cortex. Unregulated inhibition of cortex reverses the normal direction of plasticity after MD, as assayed both physiologically and anatomically (Hata and Stryker, 1994; Hata et al., 1999) . In knock-out mice in which an isoform of the GABA-synthesizing enzyme glutamic acid decarboxylase-65 (GAD65) has been disrupted, normal ocular dominance plasticity is absent; however, it can be rescued by enhancing inhibition with diazepam during the critical period (Hensch et al., 1998) . Conversely, altering visual experience can alter inhibition in cortex: MD and dark-rearing protocols, which reduce visual activity, also reduce levels of GABA and GAD (Hendry and Jones, 1986; Benevento et al., 1995) , as well as BDN F mRNA levels in cortex (Castrén et al., 1992; Bozzi et al., 1995; Schoups et al., 1995) . Rutherford et al. (1997) suggested that BDN F may link activity and inhibition. In cultured cortical neurons, activity blockade reduced the number of GABAergic neurons as well as the magnitude and frequency of spontaneous I PSC s; BDN F application reversed these effects. In the visual cortex of our BDNFoverexpressing transgenic mice, the GAD65 immunoreactivity pattern matures earlier, as does long-term potentiation from the white matter to layer II / III, both phenotypes of a premature maturation of inhibitory circuitry (Huang et al., 1999) . The developmentally accelerated BDN F expression in the transgenic mice may be kick starting the inhibitory system, advancing the normal period of plasticity such that it now begins and ends at earlier ages. Analysis of visual evoked potentials in these animals is also consistent with precocious maturation and an earlier critical period (Huang et al., 1999) . This transgenic mouse is the first visual cortex preparation to exhibit a precocious critical period, and it should prove usef ul in defining the roles of BDNF and inhibition in activity-dependent plasticity.
